CT0596
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CT0596, covering 2024-12-12 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia [EARLY_Phase 1]